Low-grade myofibroblastic sarcoma of the oral cavity

Author(s):  
Frederica Demarosi ◽  
Alessandro Bay ◽  
Laura Moneghini ◽  
Antonio Carrassi
2021 ◽  
Vol 8 (1) ◽  
pp. 1-9
Author(s):  
Primali Rukmal Jayasooriya ◽  
Chamara Athukorala ◽  
Manjula Attygalla ◽  
Balapuwaduge Ranjit Rigobert Nihal Mendis ◽  
Tommaso Lombardi

Low-grade myofibroblastic sarcoma (LGMS) is a mesenchymal tumor of myofibroblasts that occurs more frequently in adults. A series of three cases is presented to illustrate that LGMS may also occur within the oral cavity in children and adolescents. The first case (Case 1) occurred intra-osseously in the mandible, while the remaining two presented as gingival swellings and were purely restricted to soft tissue (cases 2 and 3). The intra-osseous lesion arose in a 7-year-old girl, whereas the gingival lesions were observed in a 12-year-old girl (Case 2) and a 13-year-old boy (Case 3). Histopathologically, all cases were composed of spindle shaped cells arranged into long fascicles showing mild to moderate degree of nuclear atypia. Ki-67 (MIB-1) proliferation activity was relatively low, amounting to 3–5% in all cases. Immunohistochemically, all cases showed smooth muscle actin (SMA) positivity in spindle cells, while desmin, beta catenin, cytokeratin, and CD34 were negative, resulting in a diagnosis of LGMS. In conclusion, current series of three cases of LGMSs that occurred in the oral cavity in a child and two adolescent patients is presented to highlight an emerging disease that requires additional data for further characterization.


2001 ◽  
Vol 28 (7) ◽  
pp. 383-387 ◽  
Author(s):  
Sung-Eun Chang ◽  
Jee-Ho Choi ◽  
Kyung-Jeh Sung ◽  
Kee-Chan Moon ◽  
Jai-Kyoung Koh ◽  
...  

Author(s):  
Jussara Maria Gonçalves ◽  
Ana Guadalupe Gama Cuellar ◽  
Emanuely Da Silva Chrun ◽  
Luiz Henrique Godoi Marola ◽  
Daniella Serafin Couto Vieira ◽  
...  

2020 ◽  
Vol 68 (11) ◽  
pp. 2538
Author(s):  
Kaustubh Mulay ◽  
Mrittika Sen ◽  
SantoshG Honavar

2020 ◽  
Author(s):  
Yao Xu ◽  
Guijun Xu ◽  
Xin Wang ◽  
Min Mao ◽  
Haixiao Wu ◽  
...  

Abstract Background: Low-grade myofibroblastic sarcoma (LGMS) is a rare entity with a predilection in the head and neck. There are still no optimal treatment strategies for LGMS. We aimed to investigate the role of chemotherapy and radiation treatment for LGMS. Survival estimate was performed and prognostic factors were identified.Methods: Based on the Surveillance, Epidemiology, and End Result (SEER) database, LGMS patients diagnosed between 2001 and 2015 were involved in our study. Kaplan-Meier curves and log-rank tests were used to estimate overall survival. Cox proportional hazard regression model was performed to identify prognostic factors.Results: A total of 96 eligible patients with LGMS were included, among which 86 (89.6%) received surgical treatment. Twenty-eight (29.2%) patients received radiation treatment while chemotherapy was offered to 20 (10.4%) patients. The median age was 55.0 years old with 22 cases occurred in head and neck region. The mean OS was 125.2 (95%CI 106.3-144.2) months while 1-, 3-, 5- and 10-year OS rates were 88%, 77%, 70% and 59%, respectively. Age older than 60 years, positive nodal status and no surgical treatment were independent prognostic factors for patients with LGMS. Chemotherapy and radiation were not independent prognostic factors for LGMS.Conclusions: Several prognostic factors for LGMS were revealed in this study. Surgical resection is the main therapy while chemotherapy and radiation showed limited effects on survival improvement. Thus, chemotherapy and/or radiation should not be routinely performed in LGMS.


2014 ◽  
Vol 113 (7) ◽  
pp. S92
Author(s):  
M. Oylumlu ◽  
A. Yıldız ◽  
S. Ercan ◽  
M. Oylumlu ◽  
V. Davutoğlu

Sign in / Sign up

Export Citation Format

Share Document